Global Invasive Fungal Infection Market Research Report 2022: Discoveries and Advancements of Pipeline Drugs and Facilities – Forecast to 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Invasive Fungal Infection Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027” report has been added to ResearchAndMarkets.com’s offering.

The report predicts the global invasive fungal infection market to grow with a CAGR of 4% over the forecast period from 2021-2027.

The report on the global invasive fungal infection market provides qualitative and quantitative analysis for the period from 2019 to 2027. The study on invasive fungal infection market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2019 to 2027.

The report on invasive fungal infection market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global invasive fungal infection market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global invasive fungal infection market over the period of 2019 to 2027. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

• Discoveries and advancements of pipeline drugs and facilities
• A rise in the population suffering from HIV
• Dramatic growth in the global economy

2) Restraints

• Consequences that patients might have to face during immunosuppressive treatment of fungal infection

Company Profiles

• Cidara, Basilea Pharmaceutica
• Pfizer
• GlaxoSmith Kline
• Bayer AG
• Abbott
• Merck & Co.
• Astellas Pharma Inc.
• Scynexis Inc.

Segment Covered

The Global Invasive Fungal Infection Market by Disease Type

• Candidaemi Caa and Invasive Candiasis
• Intra-abdominal Candiasis
• Cryptococcal Meningitis
• Esophageal Candidiasis
• Histoplasmosis Acute Pulmonary
• Invasive Aspergillosis
• Invasive Rhinosinusitis
• Mucormycosis
• Others

The Global Invasive Fungal Infection Market by Drug Type

• Polyenes
• Amphotericin B Deoxycholate
• Lipid Formulation Amphotericin B
• Others

For more information about this report visit https://www.researchandmarkets.com/r/i3v6pr

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900